CatalystFDA/Bio

Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets

Analyst target hikes on CRL lifted its stock fair value estimate.

What changed

Analyst target hikes on CRL lifted its stock fair value estimate.

Why it matters

Analyst target hikes on CRL lifted its stock fair value estimate. — impact context not separately stored; see What changed.

Sources